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ABSTRACT  
Natural products have played and continue to play a great role in the management of different diseases. Natural products are usually believed 
to be safer, cheaper, easily available and sometimes more efficacious than purely synthetic drugs. Diabetes mellitus is a major health problem in 
the world. There is no cure for diabetes. With the increase in a number of newer drugs for diabetes, there is the possibility  of a wide range of 
side effects that vary from one drug to another.  It is, therefore, essential to practice effective methods of the treatment and management of 
diabetes. Hence, the need to explore antidiabetic drugs of natural origin with minimal side effects is highly essential. This review provides a 
scientific perspective on the usage and research of natural traditional remedies in the management of diabetes. The aim of the present review is 
to provide a comprehensive and concise overview of the previously reported clinical trials of antioxidative natural products in the management 
of diabetes.  
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INTRODUCTION 
Diabetes mellitus (DM) is a common metabolic disorder that 
involves a defect in insulin secretion, its action, or both [1]. 
Deficiency of insulin results in chronic hyperglycemia 
(increased fasting and postprandial blood sugar (glucose) 
levels) and defect in the metabolism of protein, fat and 
carbohydrate [2].  
Diabetes mellitus is classified based on its cause and clinical 
signs and symptoms. In general, diabetes is classified into 4 
types, which include type 1 diabetes mellitus or non-insulin 
dependent diabetes mellitus, type 2 diabetes or insulin 
dependent diabetes mellitus, gestational diabetes, and other 
specific types. Non-insulin dependent diabetes mellitus is 
the major type of diabetes in younger people. Although the 
prevalence of type 1 diabetes is increasing all over the 
world, it still accounts for a minority. Children of earlier age 
groups are more prone to type 1 diabetes mellitus [3].  
Diabetes is a complex disease that can result in different 
complications; it demands a multifarious therapeutic 
approach. Drug therapy is provided to patients whose cells 
do not respond to insulin whereas insulin deficiency is 
managed by insulin injections in patients who show a total 
lack of insulin [2].  
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MANAGEMENT OF DIABETES MELLITUS USING 
NATURAL PRODUCTS 
Need for natural remedies  
Defects in insulin secretion are the one of the main causes 
that leads to Diabetes Mellitus. Recently, numerous botanical 
herbs have demonstrated antidiabetic potential through 
regulation of insulin secretion. As the long-term use of 
conventional secretagogues such as glibenclamide in 
diabetes patients tend to cause damage of b-cells due to 
overstimulation of pancreatic islet, 
Different categories of antidiabetic medications are there in 
the market for the remedial action, which includes insulin 
analogues, sulphonylureas, biguanides, dipeptidyl peptidase-
4 inhibitors, thiazolidiones, a-glucosidase inhibitors, etc, 
where the mechanism of counteracting this increased 
glucose level is different for different categories.  However, 
long term treatment and side effect of the available 
hypoglycemic medications leading towards huge demand for 
efficacious, decreased side effects and affordable agents for 
the treatment of diabetic condition. 
Most of the studies on herbal and natural products have 
reported for the better anti-diabetic effects with lower cost 
and fewer side effects than synthetic drugs. Most anti-
diabetic herbs can improve β-cell function and increase the 
secretion of insulin from the islets of Langerhans, which 
have high antioxidant power. 
 
 
Karela (Momordica charantia Linn)  
 
It is very popular for its anti-diabetic properties. It’s also rich 
in micronutrients, which are required for prevention of 
complications of diabetes. Bitter melon, also known as 
balsam pear, is a tropical vegetable widely cultivated in Asia, 
Africa and South America, and has been used extensively in 
folk medicine as a remedy for diabetes. The blood sugar 
lowering action of the fresh juice or extract of the unripe 
fruit has been clearly established in both experimental and 
clinical studies [4] .  
Bitter melon is composed of several compounds with 
confirmed anti-diabetic properties. Charantin, extracted by 
alcohol, is a hypoglycaemic agent composed of mixed 
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steroids that is more potent than the drug tolbutamide, 
which is often used in the treatment of diabetes. Momordica 
also contains an insulin-like polypeptide, polypeptide-P, 
which lowers blood sugar levels in type 1 diabetic patient. 
The oral administration of 50-60 ml of the juice has shown 
good results in clinical trials [5] .  
Excessively high doses of bitter melon juice can cause 
abdominal pain and diarrhea. Small children or anyone with 
hypoglycemia should not take bitter melon, since this herb 
could theoretically trigger or worsen low blood sugar, or 
hypoglycemia. Furthermore, diabetics taking hypoglycemic 
drugs (such as chlorpropamide, glyburide, or phenformin) 
or insulin should use bitter melon with caution, as it may 
potentiate the effectiveness of the drugs, leading to severe 
hypoglycemia [4,6] . 
Gurmar (Gymnema sylvestre Linn)  
Gymnema assists the pancreas in the production of insulin in 
Type 2 diabetes. Gymnema also improves the ability of 
insulin to lower blood sugar in both Type 1 and Type 2 
diabetes. It decreases cravings for sweet. This herb can be an 
excellent substitute for oral blood sugar-lowering drugs in 
Type 2 diabetes. Some people take 500 mg per day of 
gymnema extract [7].  
 
Pyaz/ Lehsan (Allium cepa Linn and Allium sativum Linn)  
  
Onion and garlic have significant blood sugar lowering 
action. The principal active ingredients are believed to be 
allyl propyl disulphide (APDS) and diallyl disulphide oxide 
(allicin), although other constitutents such as flavonoids may 
play a role as well.  
Experimental and clinical evidence suggests that APDS 
lowers glucose levels by competing with insulin for insulin-
inactivating sites in the liver. This results in an increase of 
free insulin. APDS administered in doses of 125 mg/ kg to 
fasting humans was found to cause a marked fall in blood 
glucose levels and an increase in serum insulin. Allicin doses 
of 100 mg/kg produced a similar effect [7,8].  
Onion extract was found to reduce blood sugar levels during 
oral and intravenous glucose tolerance. The effect improved 
as the dosage was increased; however, beneficial effects 
were observed even for low levels that used in the diet e.g. 
25 to 200 grams. The effects were similar in both raw and 
boiled onion extracts. Onions affect the hepatic metabolism 
of glucose and/or increase the release of insulin and/or 
prevent insulin’s destruction [4]. 
The additional benefit of the use of garlic and onions are 
their beneficial cardiovascular effects. They are found to 
lower lipid levels, inhibit platelet aggregation and are 
antihypertensive. So, liberal use of onion and garlic are 
recommended for diabetic patients.  
Methi (Trigonella foenum-graecum Linn)  
The active ingredient for the antidiabetic properties of 
fenugreek is in the defatted portion of the seed that contains 
the alkaloid trogonelline, nicotinic acid and coumarin.  
Fenugreek may help improve blood glucose levels in people 
with both Type 1 and Type 2 diabetes, according to several 
studies. In addition, this herbal diabetic treatment may also 
help improve blood cholesterol and triglyceride levels [4].  
Darchini (Cinnamon zylanicum Linn)  
Cinnamon comes from the inner bark of a tropical evergreen 
tree and has insulin-like properties. This herbal diabetic 
treatment can help lower blood glucose levels as well as 
cholesterol and triglycerides, and some studies suggest that 
cinnamon can help boost antioxidants in the body and may 
help reduce metabolic syndrome [9, 10].  
 
 Jamun (Eugenia Jambolana Linn)  
 
The fruit and seeds of the Jambul tree have long been used in 
Eastern traditional medicine. The extract of the jamun pulp 
showed hypoglycemic activity within 30 min of 
administration, while the seeds of the same fruit require 24 
hrs. There was increase in serum insulin level and the 
extract also inhibited insulinase activity from liver and 
kidney [7]. 
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Ghekwar (Aloe Vera)  
 
Aloe vera is a popular houseplant, has a long history as a 
multipurpose folk remedy. The plant can be separated into 
two basic products: gel and latex. Aloe Vera gel is the leaf 
pulp or mucilage, aloe latex, commonly referred to as “aloe 
juice,” is a bitter yellow exudate from the pericyclic tubules 
just beneath the outer skin of the leaves. Extracts of aloe 
gum effectively increases glucose tolerance in both normal 
and diabetics [8].  
Mango leaves (Mangifera indica Linn)  
 
Effect of leaves of Mangifera indica on Diabetic Nephropathy 
is good. It significantly inhibited glomerula’s extra cellular 
matrix expansion and accumulation and transforming 
growth factor- beta -1 over expansion in glomeruli of 
Diabetic nephropathic patients. Mangiferin has an immune-
stimulating effect on both cellular and hormonal immunity 
link. Mangiferin is a normal metabolite also to be found in 
mango leaves [4].  
Pharmacokinetics of Mangiferin in the blood after oral 
administration: A small amount of free Mangiferin is 
observed in the blood plasma after single use of Mangiferin 
at dose range between 50 mg/kg and 1000 mg/kg. Plasma 
level of Mangiferin is not over 0.05 μg/ml over 24-hour 
follow-up. Mangiferin metabolite is not detected in the blood 
within 24 hours after oral administration. Excretion of free 
Mangiferin in the urine is not over 0.1% within 24 hours [4]. 
Antioxidative natural products in clinical trials of 
diabetes 
Aloe vera Inner Leaf Gel Powder: Aloe vera inner leaf gel 
powders (UP780 and AC952) were used in patients with 
impaired fasting glucose or impaired glucose tolerance 
during an 8-week period in a double-blind, placebo 
controlled study [11]. It was reported that both AC952 and 
UP780 could markedly reduce fasting glucose and improve 
glucose tolerance and lipoprotein levels in the plasma [11]. 
However, the reduction of oxidative stress marker urinary 
F2-isoprostanes was solely noted for UP780 compared with 
the placebo. 
Black Tea: Mahmoud et al. tested the effects of black tea 
ingestion on the secretion of inflammatory cytokines and 
metabolic biomarkers in 30 patients with T2DM [12]. The 
results indicated that treatment with black tea at 200 or 600 
ml per day, for 12 weeks, resulted in significantly decreased 
glycosylated hemoglobin levels and decreased total serum 
cholesterol levels and the markers of oxidative stress. 
Furthermore, the supplementation of black tea could inhibit 
the inflammatory response including an increase in 
regulatory T cell secretion and a decrease in the production 
of proinflammatory cells [12]. 
Chamomile Tea: A single-blind randomized controlled 
clinical trial was conducted on 64 patients with T2DM to 
evaluate the effect of the antioxidative natural product 
chamomile tea [13]. Chamomile tea, at 3 g/150 ml, 3 times per 
day, was administered for 8 weeks and was shown to 
decrease the concentration of serum glycosylated 
hemoglobin, MDA, insulin, and improved insulin resistance 
[13]. Additionally, chamomile tea increased total antioxidant 
capacity of SOD, GSH, and CAT by 6.81%, 26.16%, 36.71%, 
and 45.06%, respectively [13]. This trial indicates that intake 
of chamomile tea could benefit glycemic control and 
antioxidant status in patients with T2DM. 
Nigella sativa: The long-term effect of Nigella sativa on 
T2DM patients taking standard hypoglycemic drugs was 
evaluated [14]. The 1-year treatment with Nigella sativa led to 
elevated serum total antioxidant activity and the levels of 
GSH and SOD, as compared with the non-Nigella sativa 
treated group [14]. Additionally, a significant decrease in 
fasting blood glucose and glycosylated hemoglobin and an 
improvement in insulin resistance and β-cell activity were 
observed in the Nigella sativa-treated group [14]. These 
findings suggest the potential of Nigella sativa 
supplementation as an alternative method to benefit 
patients with T2DM. 
Phyllanthus emblica Extract (PEE): PEE has a rich source 
of vitamin C, which is an important antioxidant that prevents 
platelet aggregation in healthy individuals and patients with 
coronary artery disease [15]. The 10-day treatment with PEE, 
at a dose of 500mg twice per day, was well tolerated in 
patients with T2DM, exhibited inhibitory effect on platelet 
aggregation, and prolonged the bleeding and clotting time, 
the effects of which were similar to those of the daily 
treatment with 75mg clopidogrel or ecosprin [15].  
Aged Garlic Extract: Aged garlic extract has antioxidative 
and antihyperglycemic effects [16, 17, 18]. Supplementation of 
aged garlic extract in the diet reduced oxidative stress and 
improved endothelial dysfunction in humans [19, 20]. In a 
double-blind randomized placebo-controlled crossover pilot 
trial in patients with T2DM and high cardiovascular risk 
(30% risk of a cardiovascular event in the next 10 years), the 
4-week treatment with aged garlic extract, administered 
daily at 1200 mg, did not produce significant beneficial 
effects on body weight, blood pressure, lipids, insulin 
resistance, and biomarkers of endothelial dysfunction, 
oxidative stress, and inflammation [21]. Although the authors 
indicated that the recruitment of patients with higher 
cardiovascular risk or the supplementation of aged garlic 
extract for a longer period would produce more pronounced 
effects [21]. There is need for further exploration on the 
mechanism, dose, and safety of this natural product in future 
studies. 
Salvia miltiorrhiza Hydrophilic Extract (SMHE): A 
randomized controlled clinical study was conducted, using 
SMHE, to test the protective and antioxidative properties of 
the extract in diabetic patients with chronic heart disease 
[22]. SMHE was administrated at a dose of 5g, twice per day, 
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to the patients for 60 days in addition to their anti-
hyperglycemic therapies. The serum MDA level was 
decreased by SMHE on day 30. On day 60, the serum GSH, 
SOD, paraoxonase, and glutathione reductase were 
significantly increased by SMHE. The lipid levels were not 
altered by SMHE [22]. This study indicates that SMHE has 
antioxidative activity and attenuates oxidative stress in 
diabetic patients with chronic heart disease. Determination 
of serum biomarkers for cardiac injury, cardiac remodeling, 
and cardiac dysfunction would be helpful in order to know 
the cardiac protective effect of SMHE under the diabetic 
condition 
Antioxidative Role of Natural Products in DCM 
The antioxidative effect of natural products on the 
attenuation of DCM has been extensively investigated in 
recent years [23] showing promising outcomes.  
Sulforaphane (SFN): In a STZ-induced mouse model of DM, 
treatment with SFN for either 3 months or 6 months 
significantly activated Nrf2 signaling and prevented DM-
induced cardiac oxidative damage, inflammation, 
hypertrophy, fibrosis, and dysfunction [24]. Nrf2 played a 
crucial role in the protective effect of SFN, at least on HG-
induced fibrotic response in cultured cardiomyocytes, since 
SFN lost this effect in the presence of Nrf2 siRNA [24]. 
Similarly, in a mouse model of type 2 diabetes (T2DM), SFN 
was able to activate Nrf2 antioxidant signaling, the effect of 
which restored the oxidative stress induced inhibition of 
liver kinase B1/5′ AMP-activated protein kinase 
(LKB1/AMPK) signaling pathway and prevented T2DM-
induced lipotoxicity and cardiomyopathy [25]. The crucial 
role of Nrf2 in mediating the protection by SFN against DCM 
was further demonstrated by using Nrf2 knockout mice [26]. 
Moreover, metallothionein, a potent antioxidant [27], was 
identified to be a downstream target of Nrf2 and 
predominantly mediated SFN’s protective effects on diabetic 
nephropathy [28] and DCM [26]. The effect of SFN has been 
tested in a double-blind clinical trial of T2DM, showing a 
significant improvement of insulin resistance [29]. In addition 
to the improvement of insulin resistance [29]. SFN has the 
advantage of ameliorating DCM and therefore has a good 
potential for the use in future clinical trials of DCM. 
Curcumin: Curcumin was found to reduce myocardial 
capillary sclerosis [30]; attenuate cardiac tissue damage, 
myocardial cell hypertrophy, and apoptosis; reduce 
extracellular protein accumulation; and preserve left 
ventricular function [31, 32, 33] in the hearts of STZ-induced 
diabetic rats. Mechanistically, curcumin was found to 
increase HO-1 [33], catalase (CAT), superoxide dismutase 
(SOD), and GSH [30]. In addition, the ability to reduce the 
expression of the NOX subunits p22 phox, p47 phox, p67 
phox, and gp91 phox could also account for curcumin’s 
protective effects on DCM [31, 32]. In HG-cultured neonatal rat 
cardiomyocytes, curcumin suppressed the expression of the 
NOX subunit Rac1 and reduced HG-induced oxidative stress, 
the effect of which inhibited the HG-induced apoptotic cell 
death [34]. 
Although curcumin was found to have antioxidative effects 
on DCM, the exact target through which curcumin exerted 
the functions remained unclear. Gene knockout and silencing 
approaches could aid the investigation of the exact 
mechanism of antioxidative function induced by curcumin. 
Furthermore, curcumin exhibits a poor bioavailability in 
plasma and in target tissues, which may hinder its 
therapeutic efficacy [35]. Therefore, the improvement of the 
pharmacokinetics and the increase in the plasma 
concentration of curcumin are significant therapeutic targets 
in the application of curcumin for the treatment of DCM. 
Recently, C66, a curcumin derivative with much a higher 
bioavailability [35,36],(Wu, et al, 2016; Pan, et al, 2014), was 
found to activate Nrf2 and its downstream antioxidants in 
the kidneys and aortas of the STZ-induced diabetic mice [35, 
37]. Nrf2 played a prominent role in the C66 protection 
against diabetic nephropathy, since C66 lost partial, but 
significant, protection against the DM-induced renal damage 
[35] in the Nrf2 knockout mice. 
Icariin: Icariin was reported to inhibit mitochondrial 
oxidative stress and increase SOD activity in the hearts of the 
STZ-induced diabetic rats. Icariin reduced myocardial 
collagen deposition, inhibit ventricular hypertrophy, reverse 
the DM-induced body weight loss, and improve cardiac 
function [38]. These may indicate the efficiency of inhibiting 
mitochondrial ROS generation and increasing antioxidant 
capacity in ameliorating DCM. However, blood glucose levels 
were not indicated by this report, the result of which might 
be important to know whether the amelioration of DCM was 
caused by the icariin reduction of oxidative stress or by the 
amelioration of DM. 
Flos puerariae (FPE): FPE was shown to inhibit gp91 phox 
and p47 phox, the two subunits of NOX in the hearts of STZ-
induced C57BL/6J diabetic mice [39]. Additionally, FPE 
inhibited the DM-induced ROS generation and enhanced the 
activity of SOD and glutathione peroxidase (GSH-Px), 
maintained myocardial structure, and attenuated DM-
induced apoptotic cardiac cell death [39]. Thus, FPE had the 
capability to both inhibit NOX expression and upregulate the 
expression of antioxidants in the hearts of the diabetic mice. 
Despite the speculation of c-Jun N-terminal kinase and P38 
mitogen-activated protein kinase to be the target of FPE, 
further investigations are needed to elucidate the 
mechanism of this natural product in the amelioration of 
DCM. 
Betanin: Betanin, extracted from natural pigments, was 
shown to have a protective effect against high fructose feed-
induced diabetic cardiac fibrosis in Sprague-Dawley rats [40]. 
The DM-induced expression of the cardiac profibrotic factors 
transforming growth factor β (TGF-β)1 and connective tissue 
growth factor were significantly inhibited by betanin. The 
further mechanistic study revealed the efficacy of betanin in 
inhibiting the AGE/RAGE signaling, oxidative stress, and NF-
κB under the diabetic condition. 
Given that cardiac fibrosis is a hallmark of DCM and 
contributes to cardiac dysfunction, the effect of betanin on 
the inhibition of fibrotic signaling should attract attention 
for the future studies on DCM. 
Chrysin: Chrysin was found to activate PPAR-γ; upregulate 
CAT, MnSOD, and GSH; inhibit AGE/RAGE signaling and 
oxidative stress; and attenuate apoptosis. These results 
provided evidence for PPAR-γ activation in the potential 
management of DCM. However, more studies are needed to 
clarify the exact role of chrysin and other PPAR-γ activators 
in ameliorating DCM. 
Aralia taibaiensis (sAT): sAT, with antioxidative property 
[41, 42], is a traditional Chinese medicine that is frequently 
used in patients with DM [43]. It was recently reported to 
activate Nrf2 signaling and reduce HG and glucose oxidase-
induced apoptosis, ROS, and oxidative damage in 
cardiomyocytes [44]. Nrf2 was the key factor through which 
sAT exerted the protection, since the effects of sAT were 
markedly abolished in the presence of the Nrf2 siRNA. 
Magnolia Plant Extracts (BL153 or 4-O-Methylhonokiol): 
BL153 showed beneficial effects on high-fat diet-induced 
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cardiac [45] and aortic damage [46], via inhibition of oxidative 
stress. In addition, it has been shown that 4-
Omethylhonokiol (MH), a bioactive constituent of BL153, 
reduced high-fat diet- (HFD-) induced cardiac pathological 
changes, including increased heart weight and abnormal 
echocardiography parameters [47]. The observation of the 
enhanced Nrf2/HO-1 signaling in the hearts of the MH 
treated mice [47] could be responsible for the decreased 
oxidative stress by MH. Both BL153 and MH had the 
capability to lower serum lipid level and improve insulin 
resistance in HFD animal models [25]. The effect of BL153 and 
MH should be tested in future studies on animal models of 
T1DM, since Nrf2 was shown to play a key role in protection 
against DCM in T1DM. 
Abroma augusta L. Leaf: It was tested in a streptozotocin-
nicotinamide-induced rat model of T2DM [48]. Abroma 
augusta L. leaf was found to reduce hyperglycemia, 
hyperlipidemia, membrane disintegration, oxidative stress, 
and oxidative stress-induced cell death in the kidneys and 
hearts of the diabetic rats [48]. Phytochemical screening 
revealed the presence of taraxerol, flavonoids, and phenolic 
compounds in Abroma augusta L. leaf [48]. Therefore, there’s 
need for further investigation on the specificity and off-
target effects of this natural extract although the doses 
provided in this study did not produce side effects in the 
diabetic rats. 
Aegle marmelos Leaf Extract (AME): AME was studied in a 
rat model of alloxan-induced DM for its effect on early stage 
DCM [49]. The results showed that AME evidently increased 
the antioxidants GSH, CAT, and SOD and rescued the DM-
induced cardiac necrosis and inflammation [49]. 
Dendrobium officinale Extract (DOE): was shown to 
elevate the antioxidant SOD and decrease the production of 
malondialdehyde (MDA), the accumulation of lipid, and the 
expression of the fibrotic factors TGF-β, collagen-1, and 
fibronectin, as well as the inflammatory factors NF-κB, 
tumor necrosis factor alpha, and interleukin-1 beta, in the 
hearts of STZ induced diabetic mice [50]. DOE at 300 mg/kg 
also had a significant inhibitory impact on hyperglycemia 
and cardiac hypertrophy [50]. The effects of DOE on DCM 
were evident. However, the severe cardiac remodeling, such 
as hypertrophy and fibrosis, during the 8-week period of DM 
[50], needs to be further confirmed in future studies. 
Fermented Rooibos Extract (FRE): The protective effect of 
FRE was evaluated on DCM in a STZ-induced rat model of 
DM [51]. The results showed that FRE preserved GSH activity 
in the cardiomyocytes isolated from the diabetic rats and 
prevented the cells from H2O2 or an ischemic solution-
induced generation of ROS and apoptosis [51]. This protective 
effect was more prominent as compared with that of another 
antioxidant vitamin E [51]. 
Ficus racemosa Bark Extract: Possess antioxidant activity, 
was tested in STZ-induced diabetic rats, for its effect on DCM 
[52]. The extract was found to enhance the activity of SOD and 
reduce the level of MDA in the hearts of the diabetic rats [52]. 
Ginkgo biloba Extract: Fitzl et al, 1999 treated STZ-induced 
diabetic rats with Ginkgo biloba extract and found that 
Ginkgo biloba extract could prevent the loss of myofibrils 
and the reduction of cardiomyocyte diameter [53]. Ginkgo 
biloba extract was able to increase cardiac SOD activity, 
without altering the mRNA of inducible nitric oxide synthase 
[53]. Therefore, the protective effect of this natural product 
on DCM could be due to its action in scavenging upon DM-
induced free radicals, but not blocking the source of ROS. 
Kalpaamruthaa: The effect of kalpaamruthaa on DCM was 
tested in a rat model of T2DM [54]. Kalpaamruthaa was found 
by Latha et al, (2013) to reduce the expression of NOX and 
endothelial nitric oxide synthase, the effects of which led to a 
decrease in DM-induced accumulation of cardiac lipid 
peroxides, proinflammatory cytokines, matrix 
metalloproteinase-2 and matrix metalloproteinase-9, and 
cardiac remodeling [54]. A subsequent study by the same 
group showed that kalpaamruthaa inhibited DM-induced 
cardiac lipid accumulation, chromatin condensation, and 
marginalization; increased hepatic antioxidants; improved 
insulin resistance; and lowered blood glucose level [55]. 
The ability to inhibit PKC-β and enhance Akt activity was 
suggested to account for the protective effect of 
kalpaamruthaa on DCM [54]. In a following study, the same 
group further observed that kalpaamruthaa could increase 
pancreatic antioxidants and reduce pancreatic lipid 
peroxides and carbonyl content, markers of injury in the 
plasma, heart, and liver [55]. The decreased cardiac 
expression of protease-activated receptor-1 by 
kalpaamruthaa was indicated for the cardiac protection by 
kalpaamruthaa [56]. 
These studies addressed the beneficial role of 
kalpaamruthaa in protection against DCM. It is needed to 
clarify the mechanism of this natural product, since it is still 
unclear whether the protection was due to kalpaamruthaa’s 
alteration of DM or was as a result of other mechanisms. 
Moreover, several factors were suggested to be the key 
targets of kalpaamruthaa. It would be helpful to elucidate 
the exact key factor through which kalpaamruthaa exerts the 
function by using gene silencing or gene knockout models. 
North American Ginseng (NAG): NAG (Panax 
quinquefolius) was studied for its effect on DCM in both STZ-
induced type 1 diabetic mice and DB/DB spontaneous type 2 
diabetic mice [57]. NAG had the capability to reduce the DM-
induced expression of cardiac extracellular matrix proteins 
and vasoactive factors, as well as cardiac hypertrophy and 
dysfunction in both types of the mice [57]. NAG, the effect of 
which might mediate NAG’s protection against DCM, 
diminished the DM-induced cardiac oxidative stress [57]. 
With the diverse phytochemical constituents within NAG, 
the outcome must be a combination of all the effects exerted 
by all the constituents. It would be interesting to clarify the 
key targets of the constituents that may play the major roles 
in the effect of NAG on DCM. As a result, the most effective 
constituent and the most potent target could be screened 
out. This may increase the bioavailability and specificity. 
Pongamia pinnata: Its effect on DCM was tested by using 
STZ/nicotinamide-induced type 2 diabetic rats [58]. 
Pongamia pinnata decreased blood glucose level, increased 
the antioxidants SOD and GSH in the hearts of the diabetic 
mice, and exhibited cardiac protection against DM-induced 
oxidative damage, biomarkers for cardiac injury, cardiac 
remodeling, and dysfunction [58]. The exact target of this 
natural product was not indicated in this study, which needs 
to be further elucidated in future studies. 
Syzygium cumini: Syzygium cumini was evaluated in H9c2 
cells for its protection against glucose stress-induced injury 
and was found to attenuate high glucose-induced cell 
hypertrophy and accumulation of extracellular matrix [59], 
which are hallmarks of long-term diabetic complications[60, 
27], including DCM [61]  
POLYHERBAL FOR DIABETES 
It has been observed that multiple mechanisms in the 
treatment of diabetes will effectively control the progress as 
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well as modify the deteriorating condition of the patients. To 
obtain multimodal activities in control of diabetes, certain 
purposeful mixtures of herb have been comprehensively 
evaluated for their effective uses in patients with diabetes. 
Such polyherbals are usually target the different 
pathological events throughout instigation and development 
of diabetes from different mechanistic approaches, to 
abolish the symptoms to improve the quality of life of the 
patient
 
 
Composition of polyherbal formulations in the treatment of diabetes mellitus. 
Polyherbals   Botanical composition (part used) 
GSPF kwath 
 
Gymnema sylvestre (Retz.) R.Br. (leaves), Syzygium cumini (L.) Skeels (seeds), Phyllanthus emblica L. 
(fruit), Curcuma longa L. (rhizome), Pterocarpus marsupium Roxb. (Heart-wood), Terminalia chebula Retz. 
(fruit), Cassia fistula L. (fruit), Picrorhiza kurroa Royle ex Benth. (rhizome), Swertia chirata (seeds), 
Terminalia bellirica (fruit) 
Polyherbal 
formulation 
Ferula assafoetida, Annona squamosal, Zingiber officinale (juice), Gymnema sylvestre (leaves), Tamarindus 
indica (seeds), Azadirachta indica, Trigonella foenumgraecum (seeds), Moringa oleifera (roots), Aegle 
marmelos (seeds), Cajanus cajan (leaves) 
Polyherbal 
formulation 
Salacia roxburghii (root and fruits), Salacia oblonga (root and fruits), Garcinia indica (fruits and seeds), 
Lagerstroemia parviflora (bark) 
SMK001 Coptis chinensis, Trichosanthes kirilowii 
DIASOL Eugenia jambolana, Foenum graecum, Terminalia chebula, Quercus infectoria, Cuminum cyminum, 
Taraxacum officinale, Emblica officinalis, Gymnema sylvestre, Phyllanthrus nerui, Enicostemma littorale 
DiaKure Vetiveria zizanioides (root), Hemidesmus indicus (rhizome), Strychnos 
potatorum (seed), Salacia reticulata (bark), Holarhena antidysenterica (seed), Cassia auriculata (bark), 
Trigonella graecum (seed), Acacia catechu (bark) 
DRF/AY/5001 
 
Gymnema sylvestre (leaves), Syzygium cuimini (seed), Pterocarpus marsupium (stem), Momordica 
charantia (seed), Emblica officinalis (fruit), Terminalia belirica (fruit), Terminalia chebula (fruit), Shudh 
Shilajit 
ESF/AY Aegle marmelos (leaves), Bambusa arundinacee (leaves), Eruca sativa (leaves), Aerva lanata (aerial), 
Catharanthus roseus (aerial), Ficus benghalensis (bark), Salacia reticulate (bark), Syzygium cumini (bark) 
 
 
MARKETED HERBAL MEDICATIONS FOR DIABETIC TREATMENT: ITS COMPOSITION 
Polyherbal 
Formulations 
Ingredients 
 
Diabecon[62] Sphaeranthus indicus, Tribulus terrestris, Tinospora cordifolia, Triphala, Curcuma longa, Rumex maritimus, Aloe 
vera, Swertia chirata, Ocimum sanctum, Gymnema sylvestre, Sphaeranthus indicus, Glycyrrhiza glabra, 
Commiphora wightii, Phyllanthus amarus, Boerhavia diffusa, Piper nigrum, Tribulus terrestris, Pterocarpus 
marsupium, Syzygium cumini, Tinospora cordifolia, Berberis aristata, Gmelina arborea, Asparagus racemosus, 
Abutilon indicum, Casearia esculenta, Berberis aristata, Gossypium herbaceum. 
Glyoherb[63] Gudmar (Gymnema sylvestre), Mahamejva, Katuki (Picrorhiza kurrooa), Chirayata (Swertia chirata), Karela 
(Momordica charantia), Indrajav (Holarrhena pubescens), Amala (Phyllanthus emblica), Gokshur (Tribulus 
terretris), Haritaki (Terminalia chebula), Jambu bij (Eugenia Jambolana), Methi (Trigonella foenum-graecum), 
Neem, Chandraprabha, Arogyavardhini, Haridra (Curcuma longa), Bang Bhasma, Devdar, Daruhaldi (Berberis 
aristata), Nagarmotha (Cyperus scariosus), Shuddha Shilajit, Galo 
Diabeta 
Plus[64]  
Vijayasar (Pterocarpus marsupium), Gurmar (Gymnema sylves), Jamun (Syzygium cumini), Karela (Momordica 
charantia), Shilajit (Asphaltum), 
 
 
Several research of herbal products for the remedy of 
diabetes has developed several antidiabetic products in the 
market worldwide. Few of them include, Diabecon®, 
Glyoherb, Diabeta Plus, etc. Diabecon® is a product by 
Himalaya Herbal Healthcare, is one of the well marketed 
polyherbal formulation in diabetes care [63]. Composion of 
the formulation has been depicted in table above. Aside from 
promoting b-cell repair and regeneration, it also protects the 
b-cells from oxidative stress and increases C-peptide levels. 
It mimics insulin actions by reducing HbA1c level, 
normalizing microalbuminuria and regulating the lipid 
profile. Diabecon® also possess antioxidant properties and 
claims to minimize complications in diabetic patients [63]. 
Diabecon was compared to Hyponidd, Inolter and Cogent DB 
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based on their effectiveness in reducing HbA1c [65], where 
Diabecon® showed an increased fasting insulin and C 
peptide levels compared to the other agents [65]. 
Similarly, Glyoherb is also a polyherbal antihyperglyceamic 
formulation that has additional properties of 
antihyperlipidemic and antioxidant properties. It is 
marketed to prevent, delay or improve complications such as 
retinopathy, neuropathy and retinopathy [63]. Results in 
animal testing suggested that it increases glucose tolerance 
and lowers blood glucose levels in STZ-induced type 1 
diabetic rats [66]. Additionally, treatment with Glyoherb has 
shown to reduce serum cholesterol, TGs, VLDL, LDL levels 
compared to control groups but is not as effective as 
glibenclamide. It had also shown to increase HDL levels [66]. 
Glyoherb did not exert any toxic effects in STZ-induced 
impaired kidney and liver functions rather it improved the 
kidney and liver functions [66]. On the other hand, Diabeta 
Plus is also an antidiabetic polyherbal formulation that has 
additional properties of potent immunomodulator, 
antihyperlipidemic, anti-stress and is hepatoprotective [63]. 
Use of Diabeta alone works by attacking various factors that 
can precipitate diabetic condition thus preventing or 
delaying the complications in pre-diabetics. It helps to 
decrease resistance when used in conjunction with oral 
hypoglycaemic agents, claims to relief complaints of pruritus, 
pain and polyuria caused by diabetes mellitus [63]. 
CONCLUSIONS 
Natural products with antioxidative properties have been 
shown to ameliorate diabetes in animal models. Several 
natural products have been used in clinical trials in patients 
with DM, even as traditional medicines for the treatment of 
DM for many years. The ability of these natural products in 
enhancing serum antioxidative activity and reducing serum 
oxidative stress may also be beneficial for the amelioration of 
other associated complications of diabetes. Given the 
antioxidative and even blood glucose-lowering effects of the 
natural products, they have a great potential for the future 
clinical use as alternative medicines for the management of 
DM and its associated complications. Despite the bright 
future of the natural products in the treatment of diabetes, a 
few challenges should be carefully considered before the use 
of natural products in clinical trials. Natural products have 
multiple targets. This fact may lead to off-target effects, 
including both the beneficial and the detrimental. Hence, 
more selective compounds should be developed. The 
development of SFN and curcumin, isolated from natural 
products, is a good example, although the two compounds 
have multiple targets. An in-depth mechanisms need to be 
elucidated, the result of which can provide a solid basis for 
the development of novel high-selective compounds. 
In addition, the blood glucose-lowering effect of some 
natural products is beneficial. However, the question of 
whether or not natural products lead to unstable blood 
glucose level in diabetic patients is a concern. Thus, attention 
should be paid to the fine control of blood glucose level using 
the combination of standard medicines and natural products 
as alternative medicines in the treatment of DM or its 
associated complications. 
In summary, natural products with antioxidative profiles in 
the management of diabetes on one hand have great 
potentials and face great challenges on the other. The success 
of natural products in the management of diabetes requires 
extensive studies on the mechanism, specificity, 
bioavailability, and drug-to-drug interactions. 
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